The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Frequency of Kras mutation in colorectal cancer patients in a minority-based population at a community clinical oncology program (CCOP)–participating inner-city hospital.
M. Gaddh
No relevant relationships to disclose
H. V. Poola
No relevant relationships to disclose
K. K. Batra
No relevant relationships to disclose
M. R. Mullane
No relevant relationships to disclose
M. Sekosan
No relevant relationships to disclose
T. E. Lad
No relevant relationships to disclose